Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland F Staack

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Bioanalysis|August 16, 2025
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testingGregor Jordan, Alexander Pöhler, Cordula Jany, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 19, 2007
Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?Roland F Staack, Liane D Paul, Dagmar Schmid, et al.
The AAPS Journal|February 20, 2026
In Vivo Clearance of Immune Complexes: Insights Into Human Drug/Anti-Drug Antibody Complex Clearance DynamicsEugenia Opolka-Hoffmann, Stephen Fowler, Thomas Bach, et al.
Journal of Chromatography. A|November 24, 2007
Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometryChristoph Sauer, Frank T Peters, Roland F Staack, et al.
European Journal of Pharmacology|February 6, 2004
Cytochrome P450 isoenzymes involved in rat liver microsomal metabolism of californine and protopineLiane D Paul, Dietmar Springer, Roland F Staack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 18, 2003
Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomesDietmar Springer, Liane D Paul, Roland F Staack, et al.
Bioanalysis|October 21, 2015
Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drugRoland F Staack, Gregor Jordan, Maria Viert, et al.
Journal of Mass Spectrometry : JMS|October 31, 2007
New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesChristoph Sauer, Frank T Peters, Roland F Staack, et al.
Biochemical Pharmacology|December 31, 2003
Cytochrome P450 dependent metabolism of the new designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP). In vivo studies in Wistar and Dark Agouti rats as well as in vitro studies in human liver microsomesRoland F Staack, Liane D Paul, Dietmar Springer, et al.
Journal of Mass Spectrometry : JMS|June 27, 2003
Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometryFrank T Peters, Simone Schaefer, Roland F Staack, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Bioanalysis|August 16, 2025
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testingGregor Jordan, Alexander Pöhler, Cordula Jany, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 19, 2007
Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?Roland F Staack, Liane D Paul, Dagmar Schmid, et al.
The AAPS Journal|February 20, 2026
In Vivo Clearance of Immune Complexes: Insights Into Human Drug/Anti-Drug Antibody Complex Clearance DynamicsEugenia Opolka-Hoffmann, Stephen Fowler, Thomas Bach, et al.
Journal of Chromatography. A|November 24, 2007
Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometryChristoph Sauer, Frank T Peters, Roland F Staack, et al.
European Journal of Pharmacology|February 6, 2004
Cytochrome P450 isoenzymes involved in rat liver microsomal metabolism of californine and protopineLiane D Paul, Dietmar Springer, Roland F Staack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 18, 2003
Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomesDietmar Springer, Liane D Paul, Roland F Staack, et al.
Bioanalysis|October 21, 2015
Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drugRoland F Staack, Gregor Jordan, Maria Viert, et al.
Journal of Mass Spectrometry : JMS|October 31, 2007
New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesChristoph Sauer, Frank T Peters, Roland F Staack, et al.
Biochemical Pharmacology|December 31, 2003
Cytochrome P450 dependent metabolism of the new designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP). In vivo studies in Wistar and Dark Agouti rats as well as in vitro studies in human liver microsomesRoland F Staack, Liane D Paul, Dietmar Springer, et al.
Journal of Mass Spectrometry : JMS|June 27, 2003
Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometryFrank T Peters, Simone Schaefer, Roland F Staack, et al.
Pageof 9